COMMUNIQUÉS West-GlobeNewswire

-
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
18/06/2025 -
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades
18/06/2025 -
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
18/06/2025 -
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
18/06/2025 -
TOLREMO therapeutics Announces Strengthening of Leadership: Alessandra Cesano Joins Board of Directors, Florian D. Vogl Appointed Chief Medical Officer
18/06/2025 -
Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK
18/06/2025 -
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
18/06/2025 -
Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system
18/06/2025 -
Steri-Tek va quintupler la capacité de stérilisation de son centre au Texas avec un système d’irradiation par rayons X d’IBA
18/06/2025 -
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
18/06/2025 -
Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders
18/06/2025 -
Biomea Fusion Announces Pricing of Public Offering of Securities
18/06/2025 -
Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025
18/06/2025 -
UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42
18/06/2025 -
Biomea Fusion Announces Proposed Public Offering of Securities
17/06/2025 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
17/06/2025 -
Applied Therapeutics Announces Key Leadership Appointments
17/06/2025 -
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC
17/06/2025 -
Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
17/06/2025
Pages